GHRPHover to zoomQualified Research Reference
Ipamorelin
Ipamorelin is documented for controlled research models and literature-based evaluation only.
- Regular
- $54.99
- Elite Member−10%
- $49.49
Ipamorelin is a selective pentapeptide ghrelin-receptor agonist supplied as a lyophilized research peptide. Manufactured to a high-purity analytical standard.
Research applications include ghrelin receptor selectivity, GH secretagogue pharmacology, and endocrine signaling studies.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
Ipamorelin: investigational profile.
Research Mechanism
A selective pentapeptide GHS-R1a agonist investigated for GH release without the prolactin or cortisol response seen with earlier GH secretagogues. CJC-1295 is the standard co-arm when the full GHRH + GHS-R combination is the endpoint.
Investigational Profile
Characterization by Raun and colleagues in the late 1990s put it into the GH secretagogue literature, where it has remained a reference for selectivity ever since.
Research Study Window
GH pulsatility and downstream axis endpoints are typically evaluated across four- to eight-week laboratory windows.
Pairs With
CJC-1295
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C38H49N9O5
- Molar Mass
- 711.86 g/mol
- Amino Acid Sequence
- H-Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms
- NNC 26-0161, selective GHRP
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
